FORA Quote, Financials, Valuation and Earnings

DarioHealth Corp. has a net margin of -1.95% compared to Forian, Inc.'s net margin of -41.48%. Forian, Inc.'s return on equity of -2.86% beat DarioHealth Corp.'s return on equity of -41.55%.

Forian, Inc. has a consensus price target of $2.10, signalling upside risk potential of 0.96%. On the other hand DarioHealth Corp. has an analysts' consensus of $18.25 which suggests that it could grow by 50.08%. Given that DarioHealth Corp. has higher upside potential than Forian, Inc., analysts believe DarioHealth Corp. is more attractive than Forian, Inc..

Forian, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DarioHealth Corp. has a beta of 1.047, suggesting its more volatile than the S&P 500 by 4.689%.

Forian, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Forian, Inc. pays -- of its earnings as a dividend. DarioHealth Corp. pays out -- of its earnings as a dividend.

Forian, Inc. quarterly revenues are $7.8M, which are larger than DarioHealth Corp. quarterly revenues of $5M. Forian, Inc.'s net income of -$151.2K is higher than DarioHealth Corp.'s net income of -$2.1M. Notably, Forian, Inc.'s price-to-earnings ratio is 49.00x while DarioHealth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Forian, Inc. is 2.30x versus 6.75x for DarioHealth Corp.. Usually stocks with elevated PS ratios are considered overvalued.

GoodRx Holdings, Inc. has a net margin of -1.95% compared to Forian, Inc.'s net margin of 0.57%. Forian, Inc.'s return on equity of -2.86% beat GoodRx Holdings, Inc.'s return on equity of 4.78%.

Forian, Inc. has a consensus price target of $2.10, signalling upside risk potential of 0.96%. On the other hand GoodRx Holdings, Inc. has an analysts' consensus of $4.74 which suggests that it could grow by 69.26%. Given that GoodRx Holdings, Inc. has higher upside potential than Forian, Inc., analysts believe GoodRx Holdings, Inc. is more attractive than Forian, Inc..

Forian, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison GoodRx Holdings, Inc. has a beta of 1.455, suggesting its more volatile than the S&P 500 by 45.545%.

Forian, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GoodRx Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Forian, Inc. pays -- of its earnings as a dividend. GoodRx Holdings, Inc. pays out -- of its earnings as a dividend.

Forian, Inc. quarterly revenues are $7.8M, which are smaller than GoodRx Holdings, Inc. quarterly revenues of $196M. Forian, Inc.'s net income of -$151.2K is lower than GoodRx Holdings, Inc.'s net income of $1.1M. Notably, Forian, Inc.'s price-to-earnings ratio is 49.00x while GoodRx Holdings, Inc.'s PE ratio is 32.60x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Forian, Inc. is 2.30x versus 1.28x for GoodRx Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

National Research Corp. has a net margin of -1.95% compared to Forian, Inc.'s net margin of 11.54%. Forian, Inc.'s return on equity of -2.86% beat National Research Corp.'s return on equity of 61.55%.

Forian, Inc. has a consensus price target of $2.10, signalling upside risk potential of 0.96%. On the other hand National Research Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Forian, Inc. has higher upside potential than National Research Corp., analysts believe Forian, Inc. is more attractive than National Research Corp..

Forian, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison National Research Corp. has a beta of 0.473, suggesting its less volatile than the S&P 500 by 52.662%.

Forian, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National Research Corp. offers a yield of 2.64% to investors and pays a quarterly dividend of $0.16 per share. Forian, Inc. pays -- of its earnings as a dividend. National Research Corp. pays out 45.99% of its earnings as a dividend. National Research Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Forian, Inc. quarterly revenues are $7.8M, which are smaller than National Research Corp. quarterly revenues of $34.6M. Forian, Inc.'s net income of -$151.2K is lower than National Research Corp.'s net income of $4M. Notably, Forian, Inc.'s price-to-earnings ratio is 49.00x while National Research Corp.'s PE ratio is 27.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Forian, Inc. is 2.30x versus 3.23x for National Research Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Spok Holdings, Inc. has a net margin of -1.95% compared to Forian, Inc.'s net margin of 9.46%. Forian, Inc.'s return on equity of -2.86% beat Spok Holdings, Inc.'s return on equity of 10.88%.

Forian, Inc. has a consensus price target of $2.10, signalling upside risk potential of 0.96%. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 61.66%. Given that Spok Holdings, Inc. has higher upside potential than Forian, Inc., analysts believe Spok Holdings, Inc. is more attractive than Forian, Inc..

Forian, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.416, suggesting its less volatile than the S&P 500 by 58.432%.

Forian, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings, Inc. offers a yield of 9.62% to investors and pays a quarterly dividend of $0.31 per share. Forian, Inc. pays -- of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend.

Forian, Inc. quarterly revenues are $7.8M, which are smaller than Spok Holdings, Inc. quarterly revenues of $33.9M. Forian, Inc.'s net income of -$151.2K is lower than Spok Holdings, Inc.'s net income of $3.2M. Notably, Forian, Inc.'s price-to-earnings ratio is 49.00x while Spok Holdings, Inc.'s PE ratio is 16.23x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Forian, Inc. is 2.30x versus 1.93x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.